Synaptogenix, Inc. (NASDAQ:SNPX) insider Daniel L. Alkon bought 10,000 shares of the business’s stock in a transaction that occurred on Monday, June 14th. The shares were bought at an average cost of $8.26 per share, for a total transaction of $82,600.00. Following the completion of the purchase, the insider now owns 11,484 shares of the company’s stock, valued at $94,857.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
SNPX opened at $11.13 on Friday. Synaptogenix, Inc. has a 1-year low of $2.60 and a 1-year high of $14.40.
About Synaptogenix
Synaptogenix, Inc operates as a biopharmaceutical company. It focuses on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease. The company is also evaluating therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and niemann-pick type C disease.
Recommended Story: What is the quiet period?
